| Followers | 52 |
| Posts | 14402 |
| Boards Moderated | 0 |
| Alias Born | 06/15/2014 |
Wednesday, May 15, 2024 12:23:32 AM
Good news even if results are pushed out a bit.
Recent TLPH News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 08:31:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 08:10:24 PM
- Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update • PR Newswire (US) • 05/13/2026 08:05:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/12/2026 05:22:56 PM
- Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026 • PR Newswire (US) • 05/07/2026 08:05:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/29/2026 08:34:28 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/29/2026 08:31:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 10:10:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 10:09:19 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/02/2026 04:15:30 AM
- Form 424B7 - Prospectus [Rule 424(b)(7)] • Edgar (US Regulatory) • 04/01/2026 08:37:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2026 11:57:56 PM
- Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026 • PR Newswire (US) • 03/25/2026 12:30:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/23/2026 08:05:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 12:35:09 PM
- Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update • PR Newswire (US) • 03/23/2026 12:30:00 PM
- Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026 • PR Newswire (US) • 03/18/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 08:30:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/16/2026 12:30:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2026 08:05:21 PM
- Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial • PR Newswire (US) • 03/02/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2026 01:28:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2026 01:27:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2026 01:23:20 AM
